ReGelTec, Inc. is a clinical stage medical device company based in Baltimore, MD, specializing in the development of an injectable hydrogel for the minimally invasive treatment of chronic low back pain caused by degenerative disc disease. Their proprietary hydrogel technology, known as HYDRAFIL, is injected into the intervertebral disc, where it integrates with the existing nucleus and solidifies, mimicking the biomechanical properties of a natural disc and preserving spinal motion. Early clinical results have shown significant improvements in back pain, making ReGelTec a promising solution for those suffering from degenerative disc disease.
Generated from the website